Cargando…
The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
Recent studies suggest that brain cell type specific intracellular environments may play important roles in the generation of structurally different protein aggregates that define neurodegenerative diseases. Using human induced pluripotent stem cells (hiPSC) and biochemical and vibrational spectrosc...
Autores principales: | Gustavsson, Nadja, Savchenko, Ekaterina, Klementieva, Oxana, Roybon, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444604/ https://www.ncbi.nlm.nih.gov/pubmed/34530929 http://dx.doi.org/10.1186/s40478-021-01256-w |
Ejemplares similares
-
Parkinson’s disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein–induced changes in maturation and immune reactive properties
por: Azevedo, Carla, et al.
Publicado: (2022) -
Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes
por: Rostami, Jinar, et al.
Publicado: (2017) -
Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021) -
Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015) -
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
por: García-Revilla, Juan, et al.
Publicado: (2023)